CAL
CORT icon

Capital Advisors Ltd’s Corcept Therapeutics CORT Stock Holding History

Capital Advisors Ltd’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4K Buy
+50
New +$3.02K ﹤0.01% 995
2022
Q2 		– Sell
-9
Closed – – 1051
2022
Q1 		$0 Buy
+9
New +$191 ﹤0.01% 946

Other funds holding CORT

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LTAS
Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
EF
Evanson Financial Mclean, Virginia $2.04B AUM
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Capital Advisors Ltd's CORT Position: Q2 2026 in Review

Capital Advisors Ltd opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 50 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #995 among its holdings. This is a return to the name: Capital Advisors Ltd previously reported a position in CORT as recently as Q1 2022.

Capital Advisors Ltd first reported a position in CORT in Q1 2022 and has held it in 2 quarters since. 43 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Capital Advisors Ltd held 50 shares of Corcept Therapeutics worth $4K as of Q2 2026.
  • Corcept Therapeutics was a new Capital Advisors Ltd position in Q2 2026.
  • Corcept Therapeutics made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #995 holding.
  • Capital Advisors Ltd first reported a position in Corcept Therapeutics in Q1 2022 and has held it in 2 quarters since.
  • 43 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.